Owl Creek Asset Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Owl Creek Asset Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,000	Closed	-$3.93K	–	211
2022 Q4	$3.93K	Sell	300,000 -685,565	-70%	-$21.8K	﹤0.01%	200
2022 Q3	$41K	Hold	985,565	–	–	﹤0.01%	189
2022 Q2	$78K	Hold	985,565	–	–	﹤0.01%	209
2022 Q1	$128K	Hold	985,565	–	–	0.01%	244
2021 Q4	$670K	Buy	985,565 +685,565	+229%	+$420K	0.04%	171
2021 Q3	$186K	Buy	+300,000	New	+$182K	0.01%	265

Other funds holding REVBW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Owl Creek Asset Management's REVBW Position: Q1 2023 in Review

Owl Creek Asset Management sold out of Revelation Biosciences Warrant (REVBW) in Q1 2023, closing a stake of 300,000 shares — an estimated $3.93K sold.

Owl Creek Asset Management first reported a position in REVBW in Q3 2021 and held it in 6 quarters. The position peaked at $670K in Q4 2021. 17 funds tracked by Wall St. Rank hold REVBW as of Q1 2023.

Owl Creek Asset Management reported no remaining Revelation Biosciences Warrant position as of Q1 2023 after selling out during the quarter.
Owl Creek Asset Management sold 300,000 Revelation Biosciences Warrant shares in Q1 2023, an estimated $3.93K.
Owl Creek Asset Management first reported a position in Revelation Biosciences Warrant in Q3 2021 and held it in 6 quarters.
Owl Creek Asset Management's Revelation Biosciences Warrant position peaked at $670K in Q4 2021.
17 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2023.

Based on Owl Creek Asset Management's 13F filing for Q1 2023, filed 15 May 2023.